Grant opportunityArchived
Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required)
RFA-NS-25-010 · NIH
Grant details are part of the paid plan
Award amounts, eligibility, deadlines, and the application link — plus grant alerts the moment new funding posts.
Create an account →